ストックスクリーナーアプリを入手
3.38
4.32%
0.14
アフターアワーズ：
3.20
-0.18
-5.33%
前日終値:
$3.24
開ける：
$3.24
24時間の取引高:
8,538
Relative Volume:
0.25
時価総額：
$7.76M
収益：
$5.51M
当期純損益:
$-6.16M
株価収益率:
-9.1351
EPS:
-0.37
ネットキャッシュフロー:
$-5.03M
1週間 パフォーマンス:
+10.82%
1か月 パフォーマンス:
+2.42%
6か月 パフォーマンス:
+45.69%
1年 パフォーマンス:
-27.14%
1日の値動き範囲:
$3.17
$3.38
1週間の範囲:
$3.0093
$3.40
52週間の値動き範囲:
$1.932
$10.16
Biomerica Inc Stock (BMRA) Company Profile
BMRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
3.38 | 7.76M | 5.51M | -6.16M | -5.03M | -0.37 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-11-10 | 開始されました | Colliers Securities | Buy |
| 2018-01-04 | 開始されました | B. Riley FBR, Inc. | Buy |
Biomerica Inc (BMRA) 最新ニュース
Biomerica appoints Eric B. Chin to Board of Directors By Investing.com - Investing.com South Africa
Biomerica, Inc. Announces Board and Committee Changes, Effective June 4, 2025 - marketscreener.com
Biomerica Appoints Eric B. Chin to Board - TipRanks
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair | BMRA Stock News - GuruFocus
Biomerica appoints Eric B. Chin to Board of Directors - Investing.com India
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair - TradingView
Biomerica's inFoods IBS Clinical Study Results Published in June 2025 Issue of Gastroenterology - marketscreener.com
Biomerica (BMRA) Showcases Promising Results for inFoods IBS Tes - GuruFocus
Biomerica announces publication of data from inFoods IBS clinical study - TipRanks
Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology - The Manila Times
Biomerica's inFoods® IBS Clinical Study Results Published in Jun - GuruFocus
Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology - TradingView
Biomerica announces real-world results of its inFoods IBS product - TipRanks
Biomerica (BMRA) Reports Positive Real-World Results for inFoods - GuruFocus
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System | BMRA Stock News - GuruFocus
Wall Street Backs Dell’s AI Strategy with Buy Ratings - The Globe and Mail
New IBS Treatment Cuts Pain by 49% Without Drugs: Groundbreaking Real-Time Patient Monitoring System Launches - Stock Titan
‘AI Momentum Is Real,’ Say Analysts After Google I/O 2025 - The Globe and Mail
Glass House Brands and LEEF Announce MSA for The Leaf El Paseo Dispensary and Off-Take Agreement - The Globe and Mail
Prediction: This Artificial Intelligence (AI) Semiconductor Stock Will Soar After May 28 - The Globe and Mail
Biomerica, Inc. and CLIA Laboratory Partner Filed for inFoods IBS Test - marketscreener.com
Biomerica submits application for PLA code for inFoods IBS diagnostic test - TipRanks
Biomerica (BMRA) Seeks New CPT Code for IBS Diagnostic Test | BMRA Stock News - GuruFocus
PLA Code Application Filed for inFoods IBS TestA Key Step Toward Reimbursement - The Manila Times
PLA Code Application Filed for inFoods IBS Test -- A Key Step Toward Reimbursement | BMRA Stock News - GuruFocus
PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement - TradingView
Biomerica Stock Slumps After Reverse Stock Split Announcement: Retail’s Disappointed - MSN
Biomerica (NASDAQ:BMRA) Stock Price Crosses Below Two Hundred Day Moving Average – Time to Sell? - American Banking and Market News
Biomerica announces Fortel Ulcer Test approved for sale by UAE Ministry - TipRanks
Biomerica (BMRA) Gains UAE Approval for Fortel Ulcer Test | BMRA Stock News - GuruFocus
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection - The Manila Times
United Arab Emirates Ministry of Health and Prevention Approves - GuruFocus
BMRA Stock Might Surge: Biomerica’s New Ulcer Test Now Available Across the UAE - Own Snap
United Arab Emirates Ministry Of Health And Prevention Approves Biomerica'S Fortel® Ulcer Test For Detection Of H. Pylori Infection - marketscreener.com
Biomerica Secures Major UAE Approval for Rapid H. Pylori Test as Middle East Expansion Accelerates - Stock Titan
BMRA stock touches 52-week high of $3.84 amid market fluctuations - Investing.com
Financial Health Report: Biomerica Inc (BMRA)’s Ratios Tell a Tale - DWinneX
BMRA stock touches 52-week high of $3.84 amid market fluctuations By Investing.com - Investing.com South Africa
Biomerica’s kidney disease test gains approval for sale in UAE - Yahoo Finance
Biomerica stock plummets on 1-for-8 reverse stock split - MSN
Biomerica’s kidney disease test approved for UAE market By Investing.com - Investing.com Canada
Walmart to Expand Sales of BiomericaÆS Aware Breast Self Exam; Product Will Now Be Available in over 2400 Walmart Stores - marketscreener.com
Biomerica (BMRA) Gains UAE Approval for Fortel Kidney Disease Te - GuruFocus
BiomericaFortel Kidney Disease Test Approved For Sale In UAE - marketscreener.com
Biomerica’s kidney disease test approved for UAE market - Investing.com Australia
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage - The Manila Times
Revolutionary 10-Minute Test Could Help Detect Hidden Kidney Disease in 80% of At-Risk Patients - Stock Titan
Biomerica Stock Set to Reverse Split on Monday, April 21st (NASDAQ:BMRA) - Defense World
Biomerica announces reverse stock split - Medical Buyer
Biomerica announces reverse stock split to meet Nasdaq requirements - Investing.com Australia
Biomerica announces reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com Canada
Biomerica Inc (BMRA) 財務データ
収益
当期純利益
現金流量
EPS
0.56%
1.70%
大文字化:
|
ボリューム (24 時間):